Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib

Sorafenib, an oral multikinase inhibitor, exhibits a highly variable absorption profile due to enterohepatic reabsorption and poor solubility. SYO-1644 improved the solubility of sorafenib by nanoparticulation technology leading to enhanced bioavailability. To evaluate the pharmacokinetically equiva...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, Ki-Young, Hwang, Se-jung, Park, Sang-Yeob, Lim, Hye-Jung, Jin, Mir-yung, Oh, Jae-seong, Yu, Kyung-Sang, Chung, Jae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145937/
https://www.ncbi.nlm.nih.gov/pubmed/33925058
http://dx.doi.org/10.3390/pharmaceutics13050629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145937/
https://www.ncbi.nlm.nih.gov/pubmed/33925058
http://dx.doi.org/10.3390/pharmaceutics13050629

Ejemplares similares